DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Documents Phrma Industry Profile

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 950 F STREET, NW WASHINGTON, DC 20004 www.phrma.org | www.innovation.org 2012 profile PHARMACEUTICAL INDUSTRY Key Facts…

Documents Drug development and regulation

1. DRUG DEVELOPMENT AND REGULATION www.freelivedoctor.com 2. Historical Background Why were Laws Needed? Adulteration for economic gain Early English Law - King John promulgates…

Business Schilling 06

1. Chapter 6 DEFINING THE ORGANIZATION’S STRATEGIC DIRECTION Strategic Management of Technological Innovation Melissa Schilling 2. Organization’s Strategic Direction…

Documents U.S. Regulation of Prescription Drug Marketing and Promotion October 21, 2004 Bill Ross.

Slide 1U.S. Regulation of Prescription Drug Marketing and Promotion October 21, 2004 Bill Ross Slide 2 10/21/2004U.S. Regulation of Prescription Drug Marketing and Promotion…

Documents Orphan Diseases ECD Global Alliance October 2010.

Slide 1Orphan Diseases ECD Global Alliance October 2010 Slide 2 What is an Orphan Disease? A Disease Affecting So Few People That: –There is no reasonable expectation that…

Documents Chapter 2 Law and Ethics of Pharmacy Copyright © 2004 by Elsevier Inc. All rights reserved.

Slide 1Chapter 2 Law and Ethics of Pharmacy Copyright © 2004 by Elsevier Inc. All rights reserved. Slide 2 Introduction Practice of pharmacy–governed by series of laws,…

Health & Medicine Dug development and regulation

1. DRUG DEVELOPMENT AND REGULATION Joseph Hanig, Ph.D. 2. Historical BackgroundWhy were Laws Needed?• Adulteration for economic gain• Early English Law - King John promulgatesrules…

Business Drug discoverydevelopment

1. Drug Discovery andDevelopmentHow are drugs discovered anddeveloped? 2. Basic Steps• Choose a disease• Choose a drug target• Identify a “bioassay”bioassay = A…

Business Session 13 harald_heemstra

1. Predictors of orphan drug approvalHarald E. Heemstra, [email protected] Conference on Rare DiseasesKrakow, 15 May 201015 May 2010XxxCompany XXxxCompany…

Health & Medicine Virginia Llera - Cómo optimizar la investigación en Enfermedades Raras

1. Marlene E. Haffner, MD, MPHCEO, Haffner Associates, LLCCenter for Drug Research and DevelopmentU of British ColumbiaVancouver, CanadaTuesday, October 16, 2012 2. ◦…